The interest intensified in 2016, when Mylan increased the cost of
the EpiPen by 400 percent.
Pharmaceutical giant Mylan was embroiled in a controversy about its drug pricing last year when it hiked the price of
EpiPen by more than 400 percent.
Windgap Medical, a Boston - based firm which is trying to release an alternative epinephrine auto - injector with what it says is a superior shelf life to
the EpiPen by 2018, for instance.
In fact, Mylan had recently started a major lobbying effort to encourage schools to stock
EpiPens by arguing that people with serious food allergies are always at risk, and that EpiPens were a necessary supplement to emergency medical treatment.
«Given the recent unconscionable price increases of
EpiPens by Mylan Pharmaceutical, we must look to more affordable alternatives for families dealing with allergies,» Hannon said in a statement.
«A lot of people are given
EpiPens by their pediatrician or primary care doctor because they have a positive lab test to some allergen, but they're never really evaluated by an allergist.»
Not exact matches
Rajiv Malik, president and executive director at
EpiPen maker Mylan (essentially the company's number two exec), has been named in a wide - ranging civil suit alleging drug price collusion
by numerous prominent generic drug makers.
As lawmakers and the public scrutinize dramatic price increases for other old drugs — most recently with the Mylan - owned
EpiPen, which saw its cost go up
by 500 % in the past nine years — the next flash point may be insulin, a drug both ubiquitous and complicated.
But Slavitt's letter noted that
EpiPen, since the fourth quarter of 1997, has been incorrectly reported
by its sellers as a generic drug for the rebate program.
Slavitt said
EpiPen has patent protection, has no Food and Drug Administration - approved equivalents, and was approved
by that agency under a «new drug application,» all of which make it a brand - name drug.
Mylan saw its stock dip almost a third of a percent during after - hours trading, following members of Congress saying it cheated taxpayers
by underpaying Medicaid in rebates owed on sales of its lifesaving device
EpiPen.
According to filings, Coury made roughly $ 98 million in 2016, the same year in which the company faced criticism for the price of the
EpiPen and the stock fell
by almost 30 %, according to company filings.
Mylan's CEO, Heather Bresch, later had to testify before Congress, class - action lawsuits have been filed against the company, and Mylan in May was accused of overcharging the US government
by $ 1.27 billion for
EpiPens.
Those middlemen are
by no means starving: Mylan revealed on Thursday that it wasn't pocketing the full $ 608
EpiPen wholesale price in the first place, but only $ 274 per prescription, with the remaining $ 334 split between the other parties.
Further competition looms from Teva Pharmaceutical Industries (teva), which hopes to start selling an
EpiPen - like device
by 2018.
On Wednesday, the Senate Special Committee on Aging, which has investigated price increases
by Valeant (vrx) and other drugmakers, sent its own letter to Bresch demanding information about the
EpiPen's pricing and market share since 2007.
While the drug maker has responded to the massive backlash over its extravagant price increase on the device
by boosting its patient assistance programs and introducing an authorized generic
EpiPen version at half the cost, CVS» topline price will still be significantly cheaper.
And on Thursday, Mylan expanded its discount program, offering up to $ 300 off the cost of
EpiPen with the use of a special «savings card,» thereby reducing the price for patients paying out - of - pocket
by half, the company said.
Mylan has defended its
EpiPen pricing
by pointing to patient assistance programs and coupons that reduce the device's cost.
A preliminary review
by the Office of the Attorney General revealed that Mylan Pharmaceuticals may have inserted potentially anticompetitive terms into its
EpiPen sales contracts with numerous local school systems.
NEW YORK (AP)-- Saying she is «disappointed, saddened and deeply concerned»
by the price hike of the
EpiPen, actress Sarah Jessica Parker has cut ties with the company that makes the emergency allergy treatment.
On Wednesday, regulators said the company had most likely overcharged Medicaid
by $ 1.27 billion for
EpiPens.
In the wake of the 2016
Epipen and Daraprim drug pricing scandals, and as overall prices continue to climb, investors have grown frustrated
by a lack of transparency on the part of the industry and believe a stronger message needs to be sent.
Be sure your school or provider has any medication (i.e. Benadryl,
Epipen) and your official food allergy action plan documentation (such as this one) signed
by your allergist before leaving your child alone with them.
If you think your child is having an allergic reaction during the flight, notify the flight attendant and administer the
EpiPen as you were shown
by your doctor.
Class field trips will be attended
by mother who will carry
EpiPen or the medication will be carried
by teacher in charge.
The increased price for the
EpiPen — hike
by some 400 percent — has led to bipartisan outrage toward Mylan as a generic version may soon be offered and calls for federal and state investigations grow.
He's questioning sudden price hikes in
EpiPens and Narcan, made
by companies with a corner on their markets.
Senate Health Committee Chairman Kemp Hannon on Thursday called on Attorney General Eric Schneiderman's office to investigate the hike in the cost of
EpiPens after its manufacturer boosted the price in the last year
by 75 percent.
EpiPens save lives, but the available long - term treatments offer mixed results to those exhausted
by an allergy to mold or the annual release of pollen.
Autoinjectors (such as the brand name injector is
EpiPen) should be carried
by people at high risk as a safety precaution.
Epinephrine can also be easily damaged
by light and heat, so a DIY kit would have to be prepared and carried very carefully, and refilled more often than an
EpiPen, in order to make sure the medicine doesn't become ineffective.
Hospital ER has improperly treated me
by with holding oxygen, fluids and even an
epipen during a biphasic episode.
Now we know exactly how outrageous it is: The price of the
EpiPen — an auto - injector of the inexpensive hormone ephinephrine — has skyrocketed
by more than 600 % since 2008, Money reports, from around $ 100 for the standard two - pack in 2008 to more than $ 735 today.
Congress Passes
EpiPen Bill to Fight Allergy Attacks in Schools Education Week commentary
by columnist Ross Brenneman
Epinephrine (commonly found in the form of an
EpiPen ® and better known as adrenaline, the «fight or flight» hormone) is «the principal blood - pressure raising hormone secreted
by the adrenal medulla and is used medicinally especially as a heart stimulant.»